Dance Social For Cancer Patients, Survivors and Caregivers

Breaking News
840

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Renaissance Cancer Foundation and Rhythm Room will be hosting a Dance Social to celebrate the cancer heroes in our community

Edinburg, TX- 06/20/2014- This dance social to celebrate the triumphs of cancer patients, survivors, and their caregivers is set to be an evening of joy through music and dance. Attendees will have an opportunity to dance to the rhythms of salsa, bachata, country, merengue and other latin genres. Participants will first learn basic steps taught by the professional and experienced instructors of the Rhythm Room dance studio, and will finish the night putting in some fun into those steps as they dance and practice what they learned. Our guests will also get a chance to mingle and network with others who have experienced cancer in their lives as they encourage each other and have a good time. Entrance is free and refreshments will be provided.

The dance social will take place on Friday, September 19 from 6:00 pm to 8:00 pm at the Rhythm Room studio located on 5401 N. 10th street, Suite 215, McAllen, TX.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Brush Country Medicine And Survival Conference Set For October 18, 2014
Next article
MORE Health@UTPA to address health care challenges among immigrants at presentation

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -